This application claims the benefit of PCT Application No. PCT/US2007/087412, filed on Dec. 13, 2007, which claims the benefit of U.S. Provisional Patent Application No. 60/869,739, filed on Dec. 13, 2006.
This invention relates to patient temperature control, and more particularly, to a patient temperature control system and method that reduces susceptibility to contamination which can cause patient infection.
It has long been suspected that infections acquired during a hospital stay are a major health care issue. Until recently hard data has not been available to demonstrate just how serious this problem has become. Pennsylvania was the first state to collect data tracking numbers and the results of hospital-acquired infections. The results are staggering.
For instance, applicants understand that this collected data shows that in 2004, at least 12,000 patients in Pennsylvania developed infections while in a hospital. Fifteen hundred, or about 12.5%, of those patients died. Two billion dollars in extra medical care was required to treat these patients. If these numbers are extrapolated to the rest of the U.S., nearly 100 patients are dying per day and an extra 50 billion dollars are being spent per year to fight hospital-acquired infections. The Center for Disease Control and Prevention estimates as many as two million infections are acquired in U.S. hospitals each year, resulting in approximately 90,000 deaths.
It is generally recognized that hypothermic patients are more susceptible to infection. Nonetheless, keeping the core body temperature properly regulated has grown to be the standard of care in almost every hospital and surgery center. An added benefit to keeping a patient properly regulated is the time required in Post Anesthesia Care Unit (“PACU”) areas. When a patient moves from surgery through the PACU faster, more surgeries can be performed in the same amount of time. This makes each surgery more cost-effective.
One historical difficulty with medical patient temperature therapy is contamination. This issue exists for water systems as well as convective air systems, i.e. systems with closed loop fluid flow. For example, water based hypo-hyperthermia systems can be a perfect breeding ground for bacteria. Bacteria can also collect in convective warming devices. Almost all the air drawn into current version blowers gets filtered through HEPA level filtration. This is a great initial step for cleaning up the air that is provided to the patient. Nonetheless, poor maintenance practices can negate the overall effectiveness of these filters. Contaminates can enter the unit during maintenance or manufacturing, while the filter is removed. Contaminates can also enter the hose between uses. And once these contaminates have found their way into these types of devices, the warmed atmosphere may actually assist in their further growth. Applicant is aware of information that seems to indicate that a convective system may be to blame for elevated infection rates at a hospital in Denver.
Water based systems also have comparable challenges for staying safely clean. When a water based device is cleaned, it is not practical to expect that every part of the surface area that can harbor algae or bacteria will be properly exposed to disinfectants to sanitize the system. This is especially true when fundamental mistakes are made during the cleaning process. Often, the connecting water hoses are not cleaned. If a reusable water blanket is used, the internal surface of the blankets are often not cleaned sufficiently. So if these components are not clean to begin with, the circulating water will certainly not stay clean. Moreover, there are also known instances where the distilled water used in such devices arrived at the hospital in a contaminated condition. This contaminated water was then used in a clean device only to immediately inoculate the system with contaminates. In those situations, the components started out clean, but became contaminated by the water. So although patient temperature therapy is important for patient care, and also helps hospitals reduce overall surgery costs, there is an ongoing and important need to combat hospital infection. There is also an important need to come up with innovative ways to do that, because statistics show that existing procedures are not effective, for a variety of reasons.
Clearly, attempting to keep a warming system clean is a good practice. However, the only way to confidently supply germ-free and alga-free fluid to a patient receiving temperature therapy is to completely clean the fluid just before it comes in close proximity to the patient.
Unfortunately, due to personnel limitations and/or budget restrictions, it is all too common for the fluid circuit of a patient temperature control system to be cleaned either too infrequently or insufficiently. Even with proper cleaning protocols or manufacturer suggestions in place, the cleaning of the circulating fluid of a patient temperature control system will probably not be considered as important as it should be.
The present invention seeks to address these problems in a practical and straightforward manner. More particularly, the present invention incorporates a UV light source directly into upper and lower chambers of a reservoir that contains replenishing and circulating fluid that is circulating to a patient warming/cooling device, such as a blanket. By simultaneously directing UV light into both chambers of the reservoir, during operation, this system kills bacteria that can cause infection. This eliminates, or at least reduces, the time and labor associated with the need to disinfect the flow lines and the warming/cooling device (if reused), thereby reducing labor time and costs that would otherwise be needed to accomplish these often-neglected tasks. It also prevents, or reduces, the adverse effects caused in situations where distilled water arrives at the hospital in a contaminated state.
Preferably, the UV source includes a UV tube that is operatively connected to a control button at a control panel, for manual operation. The UV bulb may also be activated automatically upon the initiation of circulating fluid through the system. Preferably, the fluid is water, but it could be any other fluid with similar heat carrying capacity. The bulb resides with a tube shaped cover, which is preferably 100% transparent and shatterproof.
A sensor mounted in the reservoir senses the emitted UV light and is operatively connected to the control panel to indicate whether the UV light is activated. Depending on the circumstances, the sensor would provide a range of conditions, to show, for instance, lamp degradation, or the existence of blocking material or an obscuration in the line of sight from the sensor to the bulb (such as impurities attached to the lamp, or the sensor itself, or water impurities), or perhaps even the effects of water temperature.
Applicants' initial testing indicates that an “on” time of about 20 minutes is long enough to sufficiently kill bacteria in the water. Nonetheless, if desired, the UV source could be cycled on/off according to a different schedule or duration, or even controlled based on various inputs of the type described above.
The prior system was already configured to minimize the volume of water in the lower reservoir, compared to the upper reservoir, to optimize efficiency in warming or cooling the circulating water. This is achieved via a removable tray that divides the two reservoir chambers, but allows fluid communication therebetween. This existing structural layout was maintained for purposes of simplicity, but also used advantageously in positioning the UV source. More particularly, the cooling coil is already spaced away from the wall of the reservoir which has the inlet and outlets. By arranging the UV source adjacent to the outlet, in a direct line of sight, all fluid flowing outwardly from the lower reservoir flows through a relatively small volume portion of the lower reservoir which is close to and within the line of sight of the UV source. Thus, the structural orientation assures UV treatment of water flowing outwardly from the housing via the outlet.
The UV source mounts within a port formed in an upper cover which covers the top of the reservoir. A gasket plugs into the port, and is shaped to hold the tube-like cover. The UV bulb extends downwardly within the cover. Both the cover and the bulb extend down through a correspondingly sized opening formed in the tray, so that the UV light emitted from the bulb will traverse directly into the circulating water in both the upper and lower compartments.
The invention preferably uses water as the fluid for warming or cooling the patient. Nonetheless, it would be possible to use other liquids, or possibly even other non-liquid fluids, depending upon the particular situation.
These and other features will be more readily understood in view of the Figures and the following detailed description.
Within housing 17, water from the outflow line 20 flows to a reservoir 22. From the tank, or reservoir 22, the circulating water flows to a pump 23, then through a heating/cooling device designated generally by reference numeral 24, and then outwardly again from the housing 17. The focus of the
An operator selectively controls operation of the system 10 via pushbutton controls shown on the control panel 32. Stated another way, the controller 26 is microprocessor-based and configured to control warming and/or cooling in a manner which cooperates with the control panel 32 via the pushbuttons which are shown best in
At the top of control panel 32,
More particularly,
The cover 44 extends downwardly through upper reservoir 22a and into lower reservoir 22b, via a port 38a formed in the tray 38 to allow the tube cover 44 to extend downwardly therethrough. The top of the cover 44 resides within a gasket 46 that is aligned within and plugs into a port 50 formed in an upper sheet 52 which defines the top boundary of the reservoir 22. A hub 58 threadably connects to the gasket 46. Other mounting configurations would be equally suitable, so long as they provide: optimum line of sight emission of the UV light into both reservoir chambers 22a, 22b, optimum transparency of the cover 44, and enhanced safety to the operator, such as the shatterproof treatment. Preferably, the tube 44 and the UV lamp 42 have about the same length, to simultaneously operate effectively in both reservoirs 22a, 22b.
Phantom lines 60, 61, and 62 of
The tray 38 is arcuately shaped to accommodate these elements, and to minimize the volume below. As stated above, this optimizes cooling and heating efficiency. And again, this structure currently exists in assignee's commercially available B-III system. But this structure is also used to advantage with respect to this invention. More particularly, water generally flows from right to left, in
In operation, circulating fluid flows from the housing 17 to the blanket 16 that covers the patient 12, along line 18, and then back to the housing 17, and particularly to the reservoir 22. In the reservoir 22, depending on the number of devices 31 connected to the housing 17 (which could be up to three blankets) and due to pressure and volume fluctuations caused by, for instance, temporary flow line occlusions, the water level of the reservoir 22 may vary. Preferably, the water level extends into upper chamber 22a. The heated or cooled water flows, as needed, downwardly into the lower reservoir 22b and eventually to the outlet 18a, to again circulate to the patient 12. While the water resides within the reservoir 22, whether in the upper chamber 22a or the lower chamber 22b, the UV light emitted from UV source 40 kills water-bourne bacteria, thereby reducing the risk of infection to the patient and also to hospital personnel. This occurs for a predetermined time duration after start-up, for example 20 minutes. During this time, the indicator 35 shows that electrical power is being supplied to the bulb 42. Also, indicator 36 will be energized to indicate that sensor 70 is receiving or detecting UV light within the tank 22. Once the indicator 36 goes out, that indicates that the UV bulb 42 has burned out, or is emitting insufficient radiation to kill bacteria. In either case, the turning off of the indicator 36 indicates the need to replace the UV bulb 42.
Despite the statistics about infection described in the background, it has been only relatively recently that this risk of infection has been studied in depth and the results disseminated widely. For example, the invention is shown with respect to a patient warming/cooling system that is commonly used to induce hypothermia in a patient. There are other applicable uses for this invention. Nonetheless, when hypothermia is induced in a patient, the infection risk becomes higher, for several reasons. For instance, if by chance a nurse or a doctor, or perhaps a member of the patient's family, accidentally puts a hole in the water blanket while the blanket is being used to induce hypothermia in the patient, the results of cross contamination could be deadly for the patient. Therefore, for these types of systems it is even more important to control the infection that can be caused by fluid bourne bacteria. The germicidal cleaning provided by this invention essentially eliminates this risk.
Also, even though it has been known for some time, in other technologies, that UV light can be Used to disinfect fluids, including liquids, and other materials, applicants are not aware of any prior efforts to incorporate the benefits of this knowledge into a patient temperature control system, particularly of the type used to induce hypothermia in a patient. Prior to applicants' testing of this invention, applicants were not aware of any prior indications that germicidal treatment of circulating fluid, in this case the use of UV light to disinfect water, could be done in a safe, practical, and an effective manner within a hospital environment, for the treatment of multiple patients. Further complicating this situation is the fact that many plastics are not made to be used in the vicinity of ultraviolet light.
While this detailed description describes a preferred embodiment of the invention, those skilled in the art will understand that these specific details are not to be read into the claims. The invention contemplates, and those skilled in the art will understand, that the various components and parameters described above are subject to a reasonable degree of variation or modification, without departing from the spirit and scope of the invention.
This application claims priority to prior U.S. Provisional Patent Application No. 60/869,739, bearing the same title, which is expressly incorporated by reference herein, in its entirety.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2007/087412 | 12/13/2007 | WO | 00 | 11/12/2009 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2008/076814 | 6/26/2008 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2817340 | Cuvier | Dec 1957 | A |
3634025 | Landry | Jan 1972 | A |
3700406 | Landry | Oct 1972 | A |
3837800 | Wood | Sep 1974 | A |
3866612 | Buker | Feb 1975 | A |
3889123 | Bosshard | Jun 1975 | A |
3894236 | Hazelrigg | Jul 1975 | A |
4318163 | Bryan | Mar 1982 | A |
4336223 | Hillman | Jun 1982 | A |
4471225 | Hillman | Sep 1984 | A |
4602162 | Sperry, III et al. | Jul 1986 | A |
4694179 | Lew et al. | Sep 1987 | A |
4769131 | Noll et al. | Sep 1988 | A |
4968437 | Noll et al. | Nov 1990 | A |
4971687 | Anderson | Nov 1990 | A |
5074322 | Jaw | Dec 1991 | A |
5304213 | Berke et al. | Apr 1994 | A |
5626768 | Ressler et al. | May 1997 | A |
5711887 | Gastman et al. | Jan 1998 | A |
5742063 | Scroggins et al. | Apr 1998 | A |
6083387 | LeBlanc et al. | Jul 2000 | A |
6197045 | Carson | Mar 2001 | B1 |
6299761 | Wang | Oct 2001 | B1 |
6464760 | Sham et al. | Oct 2002 | B1 |
6551348 | Blalock et al. | Apr 2003 | B1 |
6602409 | Kuo | Aug 2003 | B1 |
6623706 | Avnery | Sep 2003 | B2 |
6656424 | Deal | Dec 2003 | B1 |
6699267 | Voorhees et al. | Mar 2004 | B2 |
6773608 | Hallett et al. | Aug 2004 | B1 |
6911177 | Deal | Jun 2005 | B2 |
6966937 | Yachi et al. | Nov 2005 | B2 |
7066949 | Gammons et al. | Jun 2006 | B2 |
7377935 | Schock et al. | May 2008 | B2 |
20030078638 | Voorhees et al. | Apr 2003 | A1 |
20050258108 | Sanford | Nov 2005 | A1 |
20060163169 | Eckhardt et al. | Jul 2006 | A1 |
Number | Date | Country |
---|---|---|
202004001194 | Apr 2004 | DE |
763156 | Dec 1956 | GB |
9626693 | Sep 1996 | WO |
2004043313 | May 2004 | WO |
2005110298 | Nov 2005 | WO |
Entry |
---|
Chinese Patent Office, Office Action, Jun. 23, 2010, English language translation (4 pgs.), Chinese language (4 pgs.). |
International Search Report Forms: PCT/ISA/220, PCT/ISA/210, PCT/ISA/237, mailing date of Jun. 20, 2008. |
European Patent Office, Office Communication, Supplementary European Search Report (7 pgs.), publication date Jun. 11, 2012. |
Number | Date | Country | |
---|---|---|---|
20100076531 A1 | Mar 2010 | US |
Number | Date | Country | |
---|---|---|---|
60869739 | Dec 2006 | US |